Ascendis to Showcase Advances in Treatment of Achondroplasia at ICCBH 2026
COPENHAGEN, Denmark, June 25, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that the latest data from...
Day: June 26, 2026
Taysha Gene Therapies Announces Multiple Presentations Highlighting its TSHA-102 Clinical Program at the 2026 IRSF Rett Syndrome Scientific Meeting
Recently disclosed longer-term REVEAL Part A data demonstrated broad, multi-domain functional impact that deepened over time through ≥12 months post-TSHA-102...
TerrAscend Completes Oversubscribed Debt Financing, Raising $21.7 Million
A portion of the proceeds were used to retire existing higher interest rate indebtedness with the remainder available for M&ATORONTO,...
Cosmos Health Advances International Patent Application for Its Proprietary Hydrogel Weight Management Platform Across the U.S., Europe, Australia, and Canada
Building on Its Recent Acquisition of the CCX0722 Intellectual Property, Cosmos Health Owns the Technology Outright and Is Now Pursuing...
Medical Practice Pay Cools, But Hiring Pressure Holds Firm, New MGMA Report Finds
Relentless hiring strain for medical assistants and a clear shift toward automation are reshaping how practices budget for 2027Englewood, June...
BioAdaptives Completes MyndSystem™ Platform with TruShield Certification of MyndRenew™, Securing Full WADA Compliance for Professional Athletes and Expanding Market Opportunity
Certification validates the complete day-and-night neuro-performance and repair system, positioning the company for broader adoption across elite sports and high-value...
JellyFil Discloses 2026 Botanical Ingredient Sourcing, cGMP Manufacturing Standards, Caffeine Content, and Consumer Safety Considerations for Its Premium Gummy Dietary Supplement
Florida-distributed gummy supplement brand discloses ingredient origins, manufacturing standards, and consumer safety considerations for 2026Lakeland, FL, June 25, 2026 (GLOBE...
Chiesi Group and Arbor Biotechnologies Announce ABO-101 Granted Orphan Drug Designation by European Commission for Primary Hyperoxaluria
ABO-101 is an investigational gene editing therapy designed to address the underlying disease biology of PH1 by reducing hepatic oxalate...
Chiesi Group and Arbor Biotechnologies Announce ABO-101 Granted Orphan Drug Designation by European Commission for Primary Hyperoxaluria
ABO-101 is an investigational gene editing therapy designed to address the underlying disease biology of PH1 by reducing hepatic oxalate...
Valneva Announces Successful Outcome of its Annual General Meeting
Dr. Gerd Zettlmeissl is appointed as Chair of the Board of Directors Lyon (France), June 25, 2026 – Valneva SE...
Xealth Survey Defines Digital Readiness Gaps Between Healthcare Executives and Physicians
New market insights identify misaligned operational priorities in digital health and outline a framework for unificationSEATTLE, June 25, 2026 (GLOBE...
Commure Named “Overall NLP Company of the Year” in 2026 AI Breakthrough Awards
Recognition highlights Commure’s AI-native platform transforming healthcare operations at scaleMOUNTAIN VIEW, Calif., June 25, 2026 (GLOBE NEWSWIRE) -- Commure, a...
Regenix Labs Announces Educational Guide on NAD+, Cellular Energy, and Healthy Aging
New online guide explores NAD+, cellular energy production, and healthy aging research Regenix Labs logo. NEWARK, Del., June 25, 2026...
Two of Canada’s top athletes named Canadian Red Cross monthly giving ambassadors
Alphonso Davies and Leylah Fernandez partnering with the Canadian Red CrossOTTAWA, June 25, 2026 (GLOBE NEWSWIRE) -- The Canadian Red...
First Stop Health Enhances Healthy Weight Program amid Growing GLP-1 Employee Demand and Employer Costs
Program provides employers simple, clinically governed GLP-1 management options regardless of plan coverageCHICAGO, June 25, 2026 (GLOBE NEWSWIRE) -- First...
Psychedelic Science 2027 Speaker Submission Invites the Field to Bridge Promise and Practice
Psychedelic Science 2027 (PS27) convenes May 3–7, 2027, at the Colorado Convention Center in Denver under the theme “Bridging Promise...
Helus Pharma™ Announces Closing of US$50 Million Underwritten Offering
NEW YORK and TORONTO, June 25, 2026 (GLOBE NEWSWIRE) -- Helus Pharma™ (Nasdaq: HELP) (Cboe CA: HELP) (the “Company” or...
Ernexa Therapeutics Launches CEO Corner to Provide Deeper Insights into Company Progress, Scientific Strategy and Vision for Patients
New platform provides additional perspective on Ernexa's mission to deliver hope for patients through innovative, scalable cell therapies while improving...
The LaVie Institute Introduces Less-Invasive Breast Augmentation Technique with Rapid Recovery
New muscle-preserving technique is designed to help eligible patients resume work, family responsibilities, and daily activities in days rather than...
New PerfectServe Research: 85% of Healthcare Leaders Want to Switch Their Contact Center Vendors, But Most Feel Trapped
Survey of 105 IT and operational leaders reveals tech fragmentation that harms patient experience and complicates operators’ working environment New...